NCT01087853

Brief Summary

Patients often require fluid replacement during and after an operation. This is usually given through veins in the arm using an intravenous cannula and doctors have traditionally used fluid containing sodium chloride (saline). However accumulating evidence suggests that large infusions of saline are associated with adverse physiological effects including acidification of the blood and a rise in potassium and chloride levels. Studies in animals have shown that high levels of chloride in the blood and excess saline can cause blood vessels in the kidney to constrict leading possibly to a decrease in kidney function. Improvement in acid-base balance and kidney function may be observed with balanced solutions containing constituents that are more closely matched to the body's own fluid composition. However, little is known about the physiological effects of these solutions as they have only recently been developed. Magnetic resonance imaging (MRI) is a radiological modality which can now assess blood flow and supply of the kidney noninvasively without the need for the injection of radiological dyes known as contrast agents. This is now of major importance due to the possible adverse effects of MRI contrast agents leading to Nephrogenic Systemic Fibrosis (NSF), a progressive disease which has been observed in some kidney patients after receiving 'gadolinium based' contrast agents. This has therefore led to increased interest and demand for noncontrast based imaging methods. In this study we aim to compare the effects of balanced versus unbalanced fluid infusions in healthy human volunteers: We will aim to measure:

  1. 1.Blood biochemical composition and acidity
  2. 2.Kidney function and supply as measured by dynamic MRI

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 15, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 16, 2010

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

June 1, 2011

Status Verified

May 1, 2011

Enrollment Period

1 year

First QC Date

March 15, 2010

Last Update Submit

May 31, 2011

Conditions

Keywords

Fluid TherapyWater Electrolyte ImbalanceAcid Base ImbalanceRenal CirculationMagnetic Resonance Imaging

Outcome Measures

Primary Outcomes (1)

  • The primary end point of each phase of this study will be a 6 mmol difference in serum chloride concentration after infusion of the balanced and unbalanced crystalloids and colloids.

    Phase A: Times 0, 60, 90, 120, 180 and 240 min and Phase B: Times 0, 30, 60, 120, 180 and 240 min

Secondary Outcomes (1)

  • Changes in blood volume, renal and superior mesenteric arterial blood flow and vessel diameter.

    Phase A: Times 0, 60, 90, 120, 180 and 240 min and Phase B: Times 0, 30, 60, 120, 180 and 240 min

Study Arms (4)

Phase A1: Plasmalyte

ACTIVE COMPARATOR

Plasmalyte

Drug: Crystalloid

Phase A2: 0.9% Saline

ACTIVE COMPARATOR

0.9% Saline

Drug: Crystalloid

Phase B1: PlasmaVolume

ACTIVE COMPARATOR

PlasmaVolume

Drug: Colloid

Phase B2: Voluven

ACTIVE COMPARATOR

Voluven

Drug: Colloid

Interventions

2 litres intravenous infusion in 60 minutes

Phase A1: PlasmalytePhase A2: 0.9% Saline

1 litre intravenous infusion over 30 minutes

Phase B1: PlasmaVolumePhase B2: Voluven

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Male
  • Aged between 18 and 40 years
  • Weight between 65 and 80 kilograms
  • Able to give informed consent

You may not qualify if:

  • Chronic medical conditions
  • Use of any regular medications
  • History of substance abuse
  • Known hypersensitivity to study infusion fluids
  • Contraindications to MRI scanning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brain and Body MRI Centre, University of Nottingham

Nottingham, Nottinghamshire, NG7 2RD, United Kingdom

Location

Related Publications (1)

  • Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012 Jul;256(1):18-24. doi: 10.1097/SLA.0b013e318256be72.

MeSH Terms

Conditions

EdemaWater-Electrolyte ImbalanceAcid-Base Imbalance

Interventions

Crystalloid SolutionsColloids

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Isotonic SolutionsSolutionsPharmaceutical PreparationsComplex MixturesDosage Forms

Study Officials

  • Dileep Lobo, MBBS MD FRCS

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 15, 2010

First Posted

March 16, 2010

Study Start

March 1, 2010

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

June 1, 2011

Record last verified: 2011-05

Locations